Literature DB >> 7544195

Involvement of tachykinins in plasma extravasation induced by bradykinin and low pH medium in the guinea-pig conjunctiva.

M Figini1, P Javdan, F Cioncolini, P Geppetti.   

Abstract

1. The effect of bradykinin, capsaicin, substance P and low pH medium on plasma extravasation in the guinea-pig conjunctiva has been studied. Evans blue dye was measured in the conjunctiva after local instillation of the agents into the conjunctival sac. 2. Bradykinin (2-50 nmol), capsaicin (20-50 nmol) and substance P (0.5-5 nmol) caused a dose-dependent increase in plasma extravasation with the following order of potency: substance P > bradykinin = capsaicin. The effect of capsaicin (50 nmol) and substance P (5 nmol) was abolished by the tachykinin NK1 receptor antagonist, CP-99,994 (8 mumol kg-1, i.v.) (P < 0.01), whereas CP-100,263 (8 mumol kg-1, i.v.) the inactive enantiomer of CP-99,994 was without effect. CP-99,994 inhibited by 70% (P < 0.01) the effect of bradykinin. 3. The kinin B2 receptor antagonist, Hoe 140 (icatibant, 10 nmol kg-1, i.v.) abolished the response to bradykinin (50 nmol) (P < 0.01), but did not affect the responses to capsaicin (50 nmol) or substance P (5 nmol). Plasma extravasation induced by low pH medium (pH 1) was abolished by CP-99,994 (P < 0.01) and by Hoe 140 (P < 0.01). 4. The present findings suggest that: endogenous or exogenous tachykinins increase plasma extravasation in the guinea-pig conjunctiva by activation of NK1 receptors; bradykinin-induced plasma extravasation is mediated by tachykinin release from sensory nerve endings; low pH media cause plasma extravasation via release of kinins that by activation of B2 receptors release tachykinins from sensory nerve endings.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544195      PMCID: PMC1908761          DOI: 10.1111/j.1476-5381.1995.tb16329.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation.

Authors:  J J Bowden; A M Garland; P Baluk; P Lefevre; E F Grady; S R Vigna; N W Bunnett; D M McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

2.  A rapid capsaicin-activated current in rat trigeminal ganglion neurons.

Authors:  L Liu; S A Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

3.  Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder.

Authors:  A Ahluwalia; C A Maggi; P Santicioli; A Lecci; S Giuliani
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

4.  Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea.

Authors:  C Bertrand; J A Nadel; I Yamawaki; P Geppetti
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

5.  Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

Authors:  S McLean; A Ganong; P A Seymour; R M Snider; M C Desai; T Rosen; D K Bryce; K P Longo; L S Reynolds; G Robinson
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

6.  Role of peptidases and NK1 receptors in vascular extravasation induced by bradykinin in rat nasal mucosa.

Authors:  C Bertrand; P Geppetti; J Baker; G Petersson; G Piedimonte; J A Nadel
Journal:  J Appl Physiol (1985)       Date:  1993-05

7.  Neuronal pathways to the rat conjunctiva revealed by retrograde tracing and immunocytochemistry.

Authors:  T Elsås; L Edvinsson; F Sundler; R Uddman
Journal:  Exp Eye Res       Date:  1994-01       Impact factor: 3.467

8.  Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.

Authors:  W S Lee; S M Moussaoui; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

9.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.

Authors:  K Wirth; F J Hock; U Albus; W Linz; H G Alpermann; H Anagnostopoulos; S Henk; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

10.  Tachykinins and kinins in antigen-evoked plasma extravasation in guinea-pig nasal mucosa.

Authors:  F L Ricciardolo; J A Nadel; C Bertrand; I Yamawaki; B Chan; P Geppetti
Journal:  Eur J Pharmacol       Date:  1994-08-11       Impact factor: 4.432

View more
  3 in total

1.  Inhibition of bradykinin-evoked trigeminal nerve stimulation by the non-peptide bradykinin B2 receptor antagonist WIN 64338 in vivo and in vitro.

Authors:  J M Hall; M Figini; S K Butt; P Geppetti
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Contribution of B(2) receptors for bradykinin in arthus reaction-induced plasma extravasation in wild-type or B(2) transgenic knockout mice.

Authors:  R Samadfam; C Teixeira; G Bkaily; P Sirois; A de Brum-Fernandes; P D'Orleans-Juste
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Alpha 1A-adrenoceptor-mediated contractile responses of the human vas deferens.

Authors:  K Furukawa; D J Rosario; D J Smith; C R Chapple; T Uchiyama; R Chess-Williams
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.